Discrepancies between guidelines and international practice in treatment of hereditary angioedema

Allergy and Asthma Proceedings, 05/17/2012

Physicians in Latin and South America, in particular, were less likely than their international counterparts to prescribe C1 esterase inhibitor (C1–INH) and more likely to prescribe attenuated androgens and fresh frozen plasma (FFP), and European physicians were the most likely to prescribe icatibant. Over one–third of physicians described themselves as “unfamiliar“ with emerging Hereditary angioedema (HAE) therapies. Many international physicians neither follow current evidence–based studies nor adhere to the 2010 International Consensus Algorithm for treating HAE.

Print Article Summary Cat 2 CME Report